A multicenter double-blind study comparing lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 91, S3-S9
- https://doi.org/10.1016/0021-9150(91)90201-d
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group IIIPublished by American Medical Association (AMA) ,1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert PanelArchives of internal medicine (1960), 1988
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemiaClinical Pharmacology & Therapeutics, 1986
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986
- Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme a reductaseAtherosclerosis, 1982